MBMA vs. Meta-Analysis: Quick Comparison Guide Guide MBMA vs. Meta-Analysis: Quick Comparison Guide Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…CertaraOctober 8, 2025
Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings On-Demand Webinar Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings Watch Certara’s webinar with Kristin Follman to discover how TFL Studio streamlines the process to…CertaraSeptember 22, 2025
The Top 10 Things You Need to Know About ADNCA Datasets Guide The Top 10 Things You Need to Know About ADNCA Datasets Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…CertaraSeptember 11, 2025
What is a Loading Dose? BlogKnowledge Base What is a Loading Dose? Learn what a loading dose is, why it's vital for reaching therapeutic drug levels swiftly,…CertaraSeptember 10, 2025
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) CertaraSeptember 4, 2025
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) On-Demand Webinar Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…CertaraAugust 29, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraAugust 13, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Publication Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…CertaraAugust 13, 2025
Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development Blog Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…CertaraAugust 6, 2025